Insiders Nurix Therapeutics, Inc.

Equities

NRIX

US67080M1036

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-21 EDT			5-day change	1st Jan Change
21.3 ^USD	+1.57%		+40.32%	+106.40%

06-20	Nurix Therapeutics Insider Sold Shares Worth $400,216, According to a Recent SEC Filing	MT
06-18	HC Wainwright Raises Price Target on Nurix Therapeutics to $26 From $19, Maintains Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nurix Therapeutics Insider Sold Shares Worth $400,216, According to a Recent SEC Filing	06-20	MT
Nurix Therapeutics, Inc. Appoints Paula G. O?Connor as Chief Medical Officer and Pasit Phiasivongsa as Chief Technical Officer	05-28	CI
Nurix Therapeutics Names New Board Chair	05-20	MT
Nurix Therapeutics Announces Board Chair Transition	05-20	CI
Stefani A. Wolff Resigns from Nurix Therapeutics, Inc. as Chief Operating Officer and Executive Vice President of Product Development	23-04-10	CI
Nurix Therapeutics, Inc. Appoints Edward C. Saltzman to its Board of Directors	22-09-14	CI
Nurix Therapeutics, Inc. Announces Appointment of Eric Schlezinger, J.D. as Chief People Officer	22-08-03	CI
Nurix Therapeutics, Inc. announces Resignation of Clay B. Siegall as Class II Member of the Board and as Member of the Board’s Compensation Committee and Development Advisory Committee	22-05-16	CI
Nurix Therapeutics, Inc. Announces Resignation of Jeffrey K. Tong as Class II Member of the Board and as a Member of the Board's Audit Committee and Compensation Committee	22-03-07	CI
Nurix Therapeutics, Inc. Announces Appointments of Judith A. Reinsdorf and Paul M. Silva to Its Board of Directors, Effective October 1, 2021	21-09-30	CI
Insider Sell: Nurix Therapeutics	21-09-08	MT
Nurix Therapeutics, Inc. Announces Appointment of Stefani A. Wolff as Chief Operating Officer and Executive Vice President of Product Development	21-06-21	CI
Nurix Therapeutics, Inc. Announces Resignation of Leon Chen as A Member of the Nominating and Corporate Governance Committee	21-06-01	CI
Nurix Therapeutics, Inc. Appoints Clay Siegall to Board of Directors	21-06-01	CI
Nurix Therapeutics, Inc. Announces Executive Changes , Effective November 1, 2020	20-10-26	CI
Nurix Therapeutics, Inc. Announces Addition of Dr. Jason Kantor to Its Management Team	20-07-13	CI
Nurix Therapeutics, Inc. Announces Management Changes	20-06-16	CI
Nurix Therapeutics, Inc. Announces Executive Changes	19-11-14	CI
Nurix Therapeutics Announces Key Additions to its Board of Directors	19-10-08	CI
Nurix Appoints Dr. Nancy Pryer as Chief Development Officer	18-05-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Nurix Therapeutics, Inc.

Equities

NRIX

US67080M1036

Insiders

Filters